Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,249,203
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
1,727,482
-
Shares change
-
+415,519
-
Total reported value, excl. options
-
$13,663,637
-
Value change
-
+$3,303,864
-
Put/Call ratio
-
37%
-
Number of buys
-
18
-
Number of sells
-
-8
-
Price
-
$7.91
Significant Holders of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) as of Q2 2021
42 filings reported holding ATNM - Actinium Pharmaceuticals, Inc. - Common Stock as of Q2 2021.
Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,727,482 shares
of 31,249,203 outstanding shares and own 5.53% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (819,642 shares), BlackRock Inc. (222,506 shares), GEODE CAPITAL MANAGEMENT, LLC (152,678 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (99,166 shares), STATE STREET CORP (55,292 shares), BLAIR WILLIAM & CO/IL (51,466 shares), FIRST TRUST ADVISORS LP (51,273 shares), Bank of New York Mellon Corp (50,793 shares), GSA CAPITAL PARTNERS LLP (47,097 shares), and NORTHERN TRUST CORP (38,052 shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.